FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1169711000001102: Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22644901000001111 Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22645001000001111 Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Is pack of Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) false Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has active ingredient Aluminium false Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has active ingredient Magnesium hydrate false Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has active ingredient Magnesium false Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has active ingredient Aluminium hydroxide false Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has active ingredient Laxative false Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has active ingredient Trace element supplementation false Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has active ingredient Magnesium-based antacid false Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has active ingredient Magnesium hydroxide false Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has active ingredient Aluminium hydroxide gel dried false Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has VMP Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) true Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has specific active ingredient Aluminium hydroxide gel dried true Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has specific active ingredient Magnesium hydroxide true Inferred relationship Existential restriction modifier
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mucogel oral suspension (Rosemont Pharmaceuticals Ltd) 500 ml Is a True Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Inferred relationship Existential restriction modifier
Maalox oral suspension (Aventis Pharma) 500 ml Is a True Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start